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BACKGROUND: Maternal health services have been an area of focus all over the 
world due to its impact on the mothers and newborn infant. The millennium 
development goals 4 and 5 have been formulated to focus on maternal health 
services. The Department of Health in South Africa aligned to the above targets, has 
outlined essential elements of maternal care in various levels of health facilities. In this 
regard, district hospitals play an important role in delivery of maternal health care. 
Gordonia Hospital, a district hospital situated in the Northern Cape Province offers 
maternal health services in a remote area of South Africa. This study will focus on the 
utilization and costs of laboratory test in this hospital.  
 
AIM:  To describe the laboratory tests undertaken in the Maternity unit of Gordonia 
Hospital during the study period and to use this information to support maternal health 
services provided. 
 
METHODOLOGY: A cross-sectional study design was used to review routinely 
collected data from Gordonia Hospital Maternity Unit and the National Health 
Laboratory Service (NHLS) for one month period (September 2009). No primary data 
collection was done.  The setting of this study was the maternity unit at the above 
district hospital, in the Northern Cape Province.  MS Excel based tools were used to 
analyze the collected information about variables linked to the specific objectives of 
this study.  
 
RESULTS: Laboratory tests from the maternity unit of the hospital are mostly 
requested for mothers presented with hypertensive disorders of pregnancies, 
especially pre-eclampsia, and for babies with neonatal jaundice. Laboratory costs for 
the unit are around 5% of the total hospital laboratory costs and test turn-around times 
as well as recording of test results in patient files are in place.   
 
CONCLUSION:  This is the first study done in the Northern Cape Province to 
systematically study the laboratory services. The researcher hopes that the Provincial 
Department of health will use the report from this study to improve maternal health 
services in the Province. 
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CHAPTER 1 
INTRODUCTION 
 
The purpose of this study was to describe laboratory tests undertaken in the Maternity 
unit of Gordonia Hospital during the study period and also to document their costs and 
recording of results in patient files. This introductory chapter will cover background and 
justification of the study, problem statement, and its aims and objectives.  
 
1.1 BACKGROUND  
 
Maternal mortality has been on the agenda of global health organizations for the last 
20-30 years (Department of Health, 2006). There is a growing global commitment to 
reduce high maternal death rates in developing countries. The millennium 
development goals number 4 and 5 have been formulated to improve maternal health 
services (UNO, 2000). Progress towards this goal in South Africa demands national 
cooperation to assess the causes of maternal death,  provide guidelines regarding 
maternity care, and to ensure that quality health services are rendered (Department of 
Health,2007) The Department of Health has identified essential elements of maternal 
care in various levels of care provided by the  health facilities (Department of Health, 
2007). In this respect, District hospitals play an important role in the delivery of 
maternal health care. The Department of Health has suggested availability of following 
essential services in a District Hospital (Annexure A): High risk antenatal care, 
ultrasound, 24 hours labour and delivery services, clinical procedures (such as 
caesarean section, vacuum extraction and manual removal of placenta), blood 
transfusion, laboratory services and postnatal care. The laboratory tests undertaken in 
the maternity unit forms an essential component of providing optimum maternal care 
at all hospitals. 
 
Gordonia Hospital, a district hospital situated in the Northern Cape Province offers 
maternal health services in a remote area of South Africa and is the focus of this 
study.  
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1.2 STATEMENT OF THE PROBLEM 
 
It is hypothesized that as a result of the increased burden of maternity patients and 
their disease profile (such as HIV), laboratory tests and the costs of tests have been 
increasing at this Hospital’s Maternity Unit for the past few years.  One of the essential 
components of effective maternal health services is availability of laboratory and 
radiological diagnostic facilities. The laboratory services which are rendered by the 
NHLS in South Africa have been increasingly receiving attention of the Provincial 
department of health due to cost of lab services and increasing volume of lab tests. No 
correlation exist that increasing lab expenditure reflect in improvement of health care 
benefits such as maternity care.  
 
1.3 JUSTIFICATION FOR THE STUDY 
The laboratory services in the health care continue to be one of the top cost drivers 
over the past few years. The improvement of maternal health services is one of the 
priority areas for the Department of Health. Laboratory tests requested from a 
maternity unit forms an essential component of providing optimum maternal care in the 
district hospitals. The 2008/9 expenditure report for Gordonia Hospital reports that out 
of its total operational costs, 10% is spends on   laboratory costs. The contribution of 
maternity units towards lab costs has not been reported. A systematic study of 
laboratory test in the Maternity unit of this Hospital will therefore assist the Hospital.  
 
1.4 RESEARCH QUESTION 
 
To describe laboratory tests undertaken in the Maternity unit of Gordonia Hospital 
during the study period and also to document their costs and recording of results in 
patient files. 
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1.5 STUDY OBJECTIVES 
 
1.5.1 BROAD OBJECTIVE 
 
The aim of the study was to describe laboratory tests undertaken at the Maternity unit 
of Gordonia Hospital during the study period and also to document their costs and 
recording of results in patient files. 
 
 
1.5.2 SPECIFIC OBJECTIVES  
 
1. To describe the laboratory tests and the clinical profile of the patients for whom 
these tests were requested at the Maternity unit of the Gordonia Hospital during 
the study period. 
2. To document the costs of laboratory tests undertaken in the maternity unit 
during the study period. 
3. To document the recording of test results by doctors in patient files and to 
document the turn-around time for each test.   
 
1.6 SUBSEQUENT CHAPTERS 
 
Chapter one provided an overview of the study, defined the aim and objectives. The 
subsequent chapters are as follows: 
 
Chapter Two: Literature Review 
 
This chapter deals with relevant literature and studies related to the study and seeks 
to establish what current practices are in similar settings nationally and internationally. 
 
Chapter Three: Research Methodology 
 
In this chapter the research methodology, methods and techniques utilised are 
explained. 
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Chapter Four: Presentation of Results 
 
The findings of the study pertaining to aims and objectives are analysed in this 
chapter. 
 
Chapter Five: Discussion 
   
This chapter focuses on the drawing parallels from the literature and results of the 
study in an effort to explain the aims and objectives. 
 
Chapter Six: Conclusions and Recommendations 
 
In this chapter conclusions emanating from the study are cited, recommendations are 
made with regards to future studies in the area of caesarean sections.  
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CHAPTER 2 
LITERATURE REVIEW 
 
In this chapter, relevant reports and articles from the literature review on laboratory 
tests with particular reference to the tests performed for maternity patients, and their 
costs will be reviewed.  
 
2.1 MATERNAL HEALTH  
 
The World Health Organization (WHO) and other international organizations gave 
increased attention to maternal health and more specifically maternal mortality and 
morbidity in developing countries over the last decade. In South Africa, The 
Department of Health established Confidential enquiries into maternal deaths which 
has produced a fourth report in 2008 (Department of Health, 2008). It has recorded a 
20.1% increase in number of maternal deaths reported in (2005-2007) in comparison 
to the previous triennium (2002-2004). The ‘big five causes of maternal deaths’  were 
AIDS (43.7%), complications of hypertension (15.7%), obstetric haemorrhages 
(12.4%), pregnancy related sepsis (9%), and pre-existing disease (6%). The panel 
recommended improvement in four areas (knowledge development, quality of care 
and coverage of reproductive health services, establishing norms and standards and 
community developments). They recommended development and implementation of 
guidelines and protocols for effective management such as screening for HIV, 
hypertension, pre-existing medical conditions.  
 
2.2 LABORATORY TESTS USED IN MATERNITY 
 
Laboratory data are important in the medical decision making process and influence 
70% of medical diagnosis (Erasmus, and Zemlin, 2009:593). 
 
The Guidelines for Maternity Care in South Africa (2007:26) indicate essential 
screening investigations and screening tests that are not offered routinely. (Table 2.1). 
It further states that women admitted with pre-eclampsia need a full blood count 
including platelet count; serum urea and creatinine; serum uric acid; aspartate 
transaminase (AST) and urine dipstick test for protein. In suspected rhesus 
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incompatibility, the blood has to be sending for atypical antibody testing at 24, 32 and 
36 weeks (Department of Health, 2007: 110). 
 
Table 2.1 Tests for maternal health services 
 Routine tests Non-routine tests 
• syphilis serology ( Rapid Plasma 
Reagin(RPR), Wassermann 
reaction(WR),Venereal disease 
research laboratories ( VDRL);  
• Rhesus (D) blood group;  
• Heamoglobin (Hb) level;  
• HIV serology and  
• Urine dipstick for protein and glucose 
• ABO group;  
• triple screen for Down’s syndrome and 
neural tube defects;  
• rubella serology;  
• blood glucose screening;  
• cervical smear;  
• urine culture  
• full blood count (FBC) 
 
The following tests are done at the laboratory: RPR; WR; VDRL; Rhesus blood group; 
HIV serology; ABO group; Down’s syndrome; rubella serology; cervical smear; urine 
culture and full blood count. 
 
In the developed countries like the United States of America (USA) the essential tests 
for maternal care include additional tests like, urine culture and sensitivity; blood 
count, Rhesus antibody screening; culture for gonorrhoea; papanicolaou smear; 
hepatitis; and rubella antibody screening (New Jersey Department of Health and 
Senior Services, 1997), autoimmune thyroid diseases (Dosiou, Sanders,, Araki, et al., 
2008).  
 
2.3 FACTORS INFLUENCING USE OF LABORATORY TESTS USED IN 
MATERNITY   
 
Healthcare delivery organizations globally are utilizing various quality indicators to 
measure the efficacy of specific interventions as well as to identify healthcare 
improvement opportunities. These quality indicators are further being used for 
performance and outcome measurements as a means to measure, to monitor and to 
improve the quality of care and services. Evaluation of laboratory tests now started 
getting increasing attention due to spiralling cost of health care in both developed and 
developing countries.  
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Laboratory tests in maternity wards play an important role in screening, diagnosis and 
monitoring of maternity patients. However the use of these tests is influenced by 
various defined factors (such as clinical condition of patients) as well as ill-defined 
factors.  For example, the facilities which cater for unbooked and walk-in patients have 
higher costs for laboratory tests than those that have booked patients.  (Shaw, 
Gutierrez, Fridman, et al., 2008).  
 
The knowledge of health professionals plays an important role in utilization of 
laboratory tests. Mepham, Bertel Squire, Chisuwo et al (2009)  found in Malawi, that 
25% of commonly requested laboratory tests were not utilized effectively and 36% of 
the results had no influence on patient management.  This can be attributed due to 
failures of medical doctors to recognize the correct definitions for sensitivity and 
positive predictive value (Steurer, Fischer, Bachmann et al, 2002).   
 
Lack of availability of test results does lead to health professionals to repeating the 
tests which does increase the cost. Repeat tests account for a considerable portion of 
overall laboratory testing in both developed and developing countries. In a study 
conducted in Canada reported that tests repeated within 30 days of the index test 
account for 30% of total laboratory utilization. (Van Walraven, Cernat, Austin, 2006). 
 
Use of newer technologies (such as rapid testing for syphilis) also do play an 
important role and  assist in improvement of maternal health services without 
increasing cost (Levin, Steele, Atherly, et al., 2007).  
  
2.4 COSTS OF LABORATORY TESTS USED IN MATERNITY   
  
Laboratory costs are one of the major costs drivers in hospitals (van Walraven and 
Naylor, 1998:550). Laboratory tests are examples of “little-ticket” health care 
technologies, because they are commonly used, and cost the health care system large 
amounts of money (van Walraven and Naylor, 1998:550). A study conducted in Ghana 
and Benin concluded that 62% of medical costs were due to drugs and medical 
supplies including laboratory tests (Borghi, Hanson, Adjei Acquah et al, 2003). 
However, they do not specify the actual laboratory costs.  
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In an effort to cut costs, healthcare organizations are studying test utilization and its 
impact on clinical outcomes. It was found that numerous tests were performed 
unnecessarily that lead to an unnecessarily high workload and unnecessary costs 
(Erasmus and Zemlin, 2009). This is true in developed as well as developing countries 
like Malawi (Mepham, Bertel Squire, Chisuwo, et al., 2009).   
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CHAPTER 3 
METHODOLOGY 
 
In this chapter the study design, setting, scope, population are covered. The chapter 
further describes data collection, research tools and specifies methods of data 
analysis and statistical tests.  
 
3.1 INTRODUCTION 
 
The Human Research Ethics Committee of the Witwatersrand approved this study; 
authorization was also obtained from the Head of the Department of the Northern 
Cape Department of Health 
 
3.2 STUDY DESIGN 
 
A cross sectional descriptive study design was used.  
 
3.3 STUDY SETTING  
 
The study took place in the Maternity Unit of the Gordonia Hospital in the Siyanda 
District of the Northern Cape Province. 
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Figure 3.1 Siyanda District Municipality 
 
Siyanda District 
 
The Northern Cape Provincial Government has embraced District Health systems for 
improvement of health service delivery like the rest of South Africa. District health 
Services are rendered in all six local municipalities. .   
 
Gordonia Hospital 
 
Gordonia Hospital is a 191 bed district hospital in the Siyanda District of the Northern 
Cape Province that serve as a referral hospital for four out of the six sub-districts of 
the Siyanda  District, as well as the nearby Namakwa District(Northern Cape 
Department of Health,2009). The total catchment population of 236 749 of the Siyanda 
District is spread over an area of approximately 10 901km², with a population density 
of 2.02 people per km² (Northern Cape Department of Health, 2009). The service 
package for this Hospital includes mainly level 1 service and limited level 2 hospital 
services including a 24-hour service for acute gynaecological and obstetric problems 
 11 
and deliveries of most high-risk pregnancies. The hospital has a male, female, 
children’s, maternity and  a TB ward; a 24 hr casualty; 2 x theatres; a high care unit; 
specialist outpatient clinics and clinical support services for radiology, physiotherapy, 
occupational therapy, speech and hearing, pharmacy, dietetics and laboratory 
services. 
 
The Maternity Unit has 26 beds (an average of 180 deliveries per month) and is 
responsible for all referred antenatal, intra-partum, postnatal, neonatal and premature 
care. Services include emergency obstetrics & gynaecology, ultrasound, prenatal 
diagnosis, basic urogynaecology, mid trimester abortions and adequate pain relief 
systems, basic oncology, menopause and screening programmes, and preliminary 
infertility investigations.  
 
Due to remote geographical location of the Hospital, the maternity Unit has been 
receiving an increasing number of patients (A bed utilization rate of 108%in 2009, 
DHIS) over the last five years. In addition, the Maternity unit also has a high 
caesarean section rate (42.2% in 2009, DHIS) as no CS is done at the nearby 
hospitals that refer patients to Gordonia Hospital. This poses challenges of over-
expenditure and infrastructure problems for the Hospital management. An initial review 
of Hospital expenditure for 2008/ 2009 revealed Laboratory expenditure of 10% of 
hospital operational expenditure (Northern Cape Department of Health Expenditure 
report 2008/9).  Although the information for laboratory tests has been routinely 
available from the National Health Laboratory Services (NHLS) and the Hospital 
information system, no formal study has been done to systematically analyze this 
expenditure at this Hospital.  
 
3.4 STUDY SCOPE 
 
Data for this study was extracted from the records of the Maternity unit as well as the 
NHLS laboratory situated at the hospital. No primary data collection was done. No 
intervention was done as a part of this study. Records with more than 10% missing 
values were excluded. 
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3.5 STUDY POPULATION  
 
Patient records of the maternity unit as well as laboratory invoices for the month of 
September 2009. 
 
3.6 SAMPLE 
 
All the patient records and laboratory invoices for the month of September 2009 were 
reviewed. The month of September was chosen as it is in the middle of a financial 
year and is not influenced by financial decisions.  
Admissions for the study period were 183. Laboratory tests were requested for 52 
mothers and 30 babies due to their underlying medical condition. A total of 82 patients 
did not have laboratory tests because all the necessary tests were done and recorded 
at Primary Health Care level and hence, not repeated.  In 49 cases, the information 
was incomplete or the file was lost.  
The sample size for the study period was 52 mothers and 30 babies. 
 
 
 
3.7 MEASUREMENT AND DATA SOURCE 
 
3.7.1 STUDY INSTRUMENT  
 
Data collection tools based on MS excel (Appendix B) was developed and used to 
collected data from the patient records in the Maternity unit and the NHLS laboratory 
invoices for the month of September 2009.  
 
3.7.2 VARIABLES 
 
Variables that were used with their indicators highlighting what was being measured 
with each variable for each objective are listed in Table 3.1. 
The list of variables is described in the Table 3.1.  
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Table 3.1 List of variables 
Objectives Tools Variables  Indicators  
1 1 and 3 Laboratory tests 
(types, clinical 
profile of patients) 
• Types of laboratory tests (such as 
Haemoglobin, RPR, HIV) 
• Number of laboratory tests per 
category 
• Number of patients admitted  
• Proportion of admitted patients for 
whom laboratory tests were done 
• Proportion of admitted patients for 
whom laboratory tests were done 
according to age range 
• Proportion of admitted patients for 
whom laboratory tests were done 
according to gravidity(pregnancies) 
• Proportion of admitted patients for 
whom laboratory tests were done 
according to parity (children) 
 
2 2 Cost of laboratory 
tests 
• Unit cost per test 
• Total cost per test  
• Total cost for  recorded  and non-
recorded  tests 
• Expenditure on tests from the maternity 
unit as a proportion of total laboratory 
expenditure for the facility 
3 3 
 Recording  of 
laboratory results 
• Proportion of tests results recorded in 
patient files 
• Proportion of test results within 1day. 
 
 
 
3.7.3 DATA COLLECTION 
 
Data was collected from the patient records and laboratory invoices for the specific 
period (September 2009). The maternity admission book, the maternity register, the 
patient files and the electronic printouts from the laboratory were used to collect the 
data to describe the laboratory tests and the clinical profile of the patients,  the costs of 
laboratory tests,  recording of test results by doctors in patient files and  the turn-
around time of tests. Tools based on MS excel were used to extract data in coded 
form.  
 
3.7.4 DATA MANAGEMENT 
 
Frequency tables were used in the case of categorical responses and means and 
standard deviations in the case of continuous responses.   
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3.8 PILOT STUDY 
 
No pilot study was conducted as the data for this study were routinely collected 
through hospital information system.  
 
3.9 ETHICAL CONSIDERATIONS 
  
Approval to do the research was given by the Hospital Manager as well as the Head of 
Department of Health in the Northern Cape Province. Approval was also given by the 
Wits University Human Research Ethics Committee (M 10830). Confidentiality when 
working with patient records was assured by using codes. The result or outcome of the 
study will be available to the hospital manager as well as the head of department. 
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CHAPTER 4 
RESULTS 
 
The results obtained from the analysis of data are presented in this chapter 
 
4.1 LABORATORY TEST & THE CLINICAL PROFILE OF PATIENTS TESTED 
 
4.1.1 NUMBER OF PATIENTS ADMITTED 
 
A total number of 183 patients were admitted during the study period.  
 
4.1.2  NUMBER OF TESTS DONE  
 
 Laboratory tests were done for 52 mothers and 30 babies born during the study 
period.  
 
4.1.2.1.       MOTHER  
 
The test done for mothers is described in table 4.1. There were a total of 524 tests 
done within 24 categories of tests.  The most common tests done during the period 
was Uric Acid (UA) with 26 out of 52 pts, followed by Urea Creatinine  Electrolytes 
(UECA) with 24, Platelets (PLT) with 23, and Aspartate transaminase (AST) & Lactate 
dehydrogenase (LDH) & Haemoglobin (HB) with 21, and Alanine transaminase (ALT) 
with 20.  The highest number of tests done was UA with 35 out of the 524, UECA (32), 
PLT (30), LDH (29), followed by ALT, AST and HB all with 26 tests.  
 
Other tests done were Rhesus factor (RH) with 13, Rapid plasma regain (RPR) - 11, 
Urine culture (CULUR - 7, Urine protein (UPROT) - 6, HIV & Liver function test (LFT) 
5, International normalised ratio (INR) - 4, Genital Swap (CULGE) & Sensitivity  & Full 
blood count (FBC) - 3, Sputum culture (CULSP) & Cut-up (C/UP) & Histology - 2 and 
Differential Count (DIFFM), Tuberculosis (TBA), CREATINE and UREA with 1.   
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Table 4.1 Number of laboratory tests done for mothers 
Test Name No pt No tests 
UA 26 35 
UECA 24 32 
PLT 23 30 
LDH 21 29 
AST 21 26 
ALT 20 26 
HB 21 26 
RH 13 13 
RPR 11 11 
UPROT 6 8 
HIV 5 7 
CULUR 7 7 
SENS 3 5 
LFT 5 5 
CULSP 2 4 
INR 4 4 
CULGE 3 3 
FBC 3 3 
TBA 1 3 
C/UP 2 2 
HISTO 2 2 
DIFFM 1 1 
CREATINE 1 1 
UREA 1 1 
TOTAL  524 
 
4.1.2.2.   NEONATES 
 
The test done for neonates is described in table 4.2. There were a total of 163 tests 
done within 21 categories of tests.  The most common tests done during the period 
was FBC with 24 out of 30 pts, followed by PBIL with 22, and CRP with 20. The 
highest number of tests done was Paediatric Bilirubin (PBIL) with 65 out of the 163, 
FBC with 34 and C-reactive protein (CRP) with 29 tests.  
 
Other test done were LDH & UECA (5), Cystic fibrosis (CSF) & TBA (4), CULSP (3) 
and Microbiology Cathetetip (CULCT), Hematocrit (HCT),SENS, DIFFM, HERP, 
CULUR, TBCUL, CULPU, Microbiology Blood Culture (CULBC), 
Toxoplasmosis(TOXO), Cyto megalo virus(CMV), HB all with ( 1).   
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Table 4.2 Number of laboratory tests done for neonates 
Test Name No pt No tests 
PBIL 22 65 
FBC 24 34 
CRP 20 29 
UECA 5 5 
LDH 2 5 
CSF 4 4 
TBA 1 4 
CULSP 1 3 
HIV 2 2 
CULCT 1 1 
HCT 1 1 
DIFF 1 1 
HERP 1 1 
CULUR 1 1 
TBCUL 1 1 
CULPU 1 1 
CULBC 1 1 
TOXO 1 1 
CMV 1 1 
HB 1 1 
SENS 1 1 
TOTAL 
 163 
 
 
4.1.3  PROFILE OF PATIENTS 
 
The profile of patients is described according to age, gravidity- and parity status.  
 
4.1.3.1.     AGE 
The mean age (average age) for the participants is 26.4 years and the standard 
deviation (average deviation from the mean age) is 6.1 year. 
 
Table 4.3 reflects the number/proportion of patients tested according to age range. 
Twenty four or 46.2% of the 52 patients that were tested was in the age range 26-35 
years, followed by 20 or 38.5% within the range of 19 -25 years of age. Only 5 or 9.6 
% of the tested patients were in the age range of 13 -18 year and 3 or 5.7% of the 
patients were in the age range ≥35 years.    
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Table 4.3 Age of the participants 
Age in years Number of patients tested Proportion of patients tested 
Median (IQR)   
Age groups   
13-18 years 5 9.6 
19-25 years 20 38.5 
26-35 years 24 46.2 
≥35 years 3 5.7 
Total 52 100 
 
4.1.3.2.    GRAVIDITY  
 
Table 4.4 reflects the number/proportion of patients tested according to gravidity 
(pregnancies). In twenty eight percent or 15 of women tested it was the 1st pregnancy, 
40.4 % or 21 had a gravidity status of 2-3 pregnancies; whiles 16 or 30.8% of patients 
were in the gravidity range of ≥4.   
 
Table 4.4 Gravidity status of the participants 
Gravidity Number of patients Proportion of patients 
Median (IQR) 3 ()  
1 15 28.8 
2-3 21 40.4 
≥4  16 30.8 
TOTAL  52 100 
 
4.1.3.3    PARITY 
 
Table 4.5 reflects the number/proportion of patients tested according to parity 
(children). Twenty one patients or 40.4% of patients tested were in the parity range of 
1-3 children, whiles 16 or 30.8% and 15 or 28.8% of patients were in the parity ranges 
of ≥4 and 0 children respectively.  
 
 
 
 
 
 
 19 
Table 4.5 Parity of the participants 
Parity Number of patients  Proportion of patients  
Median (IQR) 1 (0-3)  
0 15 28.8 
1-3 21 40.4 
≥4 16 30.8 
TOTAL  52 100 
 
4.2 COST OF LABORATORY TESTS AND HEALTH EXPENDITURE 
 
4.2.1        COST OF LABORATORY TESTS 
 
4.2.1.1      MOTHERS 
 
Table 4.6 reflects the unit as well as total costs per tests for the mothers tested. The 
expenditure for tests done for mothers was 62.1% of the total laboratory costs at the 
maternity unit. Liver Function Tests (LFT) was the most expensive test costing 
R256.56, followed by histology at R187.17, urine protein (UPROT) at R140.58 and 
UEAC at R96.28t. Other more expensive tests were sensitivity test cost R57.88, full 
blood count (FBC) cost R48.30 and urine culture cost R45.63. The rest of the test 
ranged from R37.84 to R15.03, HB costing R15.03. 
 
The highest proportion of tests for mothers, were those of UECA with 23.3%, followed 
by 9.7 % for LFT, 8.5% for urine protein, 8.2% for AST, ALT and LDH. 
 
The amount for the total repeat tests for mothers was R1985.12, 15% of the total 
expenditure for mothers. 
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Table 4.6 Cost of laboratory tests (mother)  
Test No pt No tests Unit cost per test Total cost per test 
UECA 24 32 96.28 3080.96 
LFT 5 5 256.56 1282.80 
UPROT 6 8 140.58 1124.64 
AST 21 26 37.84 1097.36 
ALT 20 26 37.84 1097.36 
LDH 21 29 37.84 1097.36 
UA 26 35 26.61 931.35 
PLT 23 30 17.81 534.30 
HB 21 26 15.03 390.78 
HISTO 2 2 187.17 374.34 
RH 13 13 28.49 370.37 
CULUR 7 7 45.63 319.41 
SENS 3 5 57.88 289.40 
HIV 5 7 36.73 257.11 
RPR 11 11 16.37 180.07 
INR 4 4 39.40 157.60 
FBC 3 3 48.30 144.90 
CULSP 2 4 35.41 141.94 
CULGE 3 3 35.41 106.53 
TBA 1 3 31.27 93.81 
C/UP 2 2 35.39 70.78 
DIFFM 1 1 26.49 26.49 
CREATINE 1 1 25.27 25.27 
UREA 1 1 25.27 25.27 
TOTAL  524  13 220.20 
 
4.2.1.2      NEONATES 
 
Table 4.7 reflects the unit as well as total costs per tests for the babies tested. The 
expenditure for tests done for neonates was 33.8% of the total laboratory costs for the 
maternity unit. Cystic Fibrosis(CSF)  were the most expensive test at R106.19/test , 
followed by UEAC at R96.28/tests, TB Culture at R72.98/test, C-reactive protein(CRP)  
at R60.77/test,  Full blood Count (FBC) at R48.30/test and  Paediatric Bilirubin at 
R51.76/test. Other expensive tests were, culture urine (CULUR) at R45.63/test and 
LDH at R37.84/test. The rest of the test ranged from R36.73 till R15.03. 
 
The highest proportion spend for babies  per category of tests were those of paediatric 
bilirubin  with 26.9%, followed by 24.5 % for CRP, 22.8% for full blood count (FBC) 
and 6.6 % for UECA. 
 
The amount for the total repeat tests for neonates was R2364.09. That calculates to a 
32.8% of the total expenditure for neonates. 
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Table 4.7 Cost of laboratory tests (neonate)  
Test No pt No tests Unit cost per test Total cost per test 
PBIL 22 65 29.38 1909.70 
CRP 20 29 60.77 1762.33 
FBC 24 34 48.30 1642.20 
UECA 5 5 96.28 481.40 
CSF 4 4 106.19 424.76 
LDH 2 5 37.84 189.20 
TBA 1 4 31.27 125.08 
CULSP 1 3 35.41 106.23 
HIV 2 2 36.73 73.46 
TBCUL 1 1 72.98 72.98 
SENS 1 1 57.88 57.88 
HERP 1 1 52.87 52.87 
CULUR 1 1 45.63 45.63 
CULCT 1 1 35.41 35.41 
CULPU 1 1 35.41 35.41 
CULBC 1 1 35.41 35.41 
TOXO 1 1 35.39 35.39 
HCT 1 1 32.72 32.72 
CMV 1 1 32.72 32.72 
DIFF 1 1 26.49 26.49 
HB 1 1 15.03 15.03 
TOTAL  163  7 192.30 
 
4.2.1.3    LABORATORY COSTS FOR MOTHERS AGAINST THOSE FOR BABIES 
 
The average number of tests done for mothers was 10.1. This is twice that for babies, 
as the average number of tests for babies was 5.4. The average cost per patient for 
mothers were more than those for babies; however the average costs per test for 
mothers were almost half the costs less than per test for babies. Test for babies are 
more expensive in comparison with the test requested for mothers. 
 
Table 4.8 Costs of laboratory tests for mothers against those for babies 
 
 Mothers (n=52) Babies (n=30) 
Average number of laboratory tests 10.1 5.4 
Average laboratory cost per patient R254.23 R239.74 
Average cost per laboratory test R25.23 R44.12 
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4.2.2.      HEALTH EXPENDITURE 
 
The total expenditure for Gordonia Hospital during the study period was 
R27 719 475.84. The total expenditure for laboratory services for Gordonia Hospital 
during the study period was R423 470.17. The total laboratory costs for the maternity 
unit during the study period was R21 280. The proportion spends on the maternity unit 
as part of the total laboratory expenditure was 5% whiles the proportion spends as 
part of the total hospital expenditure was 0.08%. 
 
The proportion spends on mothers as a part of the total maternity unit expenditure was 
62.1%, while the proportion for neonates was 33.8%. The remainder 4.1% spending 
was on administrative costs. 
 
A total amount of R4 349.21 was spending on repeat tests, 20.4% of the total 
laboratory expenditure for the maternity unit.  
 
 All tests were recorded in the patient files.  
 
4.3 RECORDING OF LABORATORY RESULTS 
 
The recording of laboratory results refers to turnaround times, repeat tests and 
recording in the patient files. 
 
4.3.1.       RECORDING OF LABORATORY RESULTS FOR MOTHERS 
   
Table 4.9 presents recording of laboratory results for mothers. A total of 16.6% of test 
results were recorded within 2days. The categories of results reported within 2days 
was Rhesus factor (RH), Genital swap (CULGE), uric acid (UA) and urine culture. 
Repeat tests were done for 41.6 % of the total categories of tests. The most repeats 
happened in a range of 1-3. Tests repeated for uric acid was 9, for UECA - 8, PLT - 7, 
and for AST and HB 5 each. All tests were recorded by the doctors in the patient files. 
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Table 4.9 Recording of laboratory tests for mothers 
Test Name No pt No tests Turnaround 
Time 
Repeats No Repeats Check 
RH 13 13 1 (1-2) 0 0 13 
RPR 11 11 1 0 0 13 
UECA 24 32 1  4 2 (1-3) 24 
HIV 5 7 1  2 2 5 
SPUTUM  2 4 1 1 1 2 
DIFFM 1 1 1 0 0 1 
CULGE 3 3 1 (1-2) 0 0 3 
SENS 3 5 1 1 2 3 
PLT 23 30 1 1 2 23 
AST 21 26 1 2 3-4 21 
ALT 20 26 1 3 1-3 20 
LDH 21 29 1 4 1-3 21 
UA 26 35 1-2 4 1-3 26 
CULUR 7 7 1-2 0 0 7 
C/UP 2 2 1 0 0 1 
HISTO 2 2 1 0 0 1 
HB 21 26 1 3 1-2 21 
FBC 3 3 1 0 0 3 
LFT 5 5 1 1 2 5 
UPROT 6 8 1 1 2 6 
INR 4 4 1 0 0 4 
TBA 1 3 1 1 2 1 
CREATINE 1 1 1 0 0 1 
UREA 1 1 1 0 0 1 
TOTAL  524     
 
4.3.2       RECORDING OF LABORATORY RESULTS FOR NEONATES  
   
Table 4.10 presents recording of laboratory results for babies. All test results were 
recorded the same day.  
 
Repeat tests were done for 19 % of the total tests. The highest total of repeats was in 
the range of 1-3. The repeat tests were for paediatric bilirubin with 43 repeats, full 
blood count with 10, CRP with 9 and sputum culture with 2 tests. 
 
All tests were recorded by the doctors in the patient files. 
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Table 4.10 Recording of laboratory tests for neonates  
 
Test Name No pt No tests Turnaround 
Time 
Repeats No Repeats Check 
CRP 20 29 1 4 2-3 29 
PBIL 22 65 1 11 2-7 65 
UECA 5 5 1 0 0 5 
HIV 2 2 1 0 0 2 
CULSP 1 3 1 1 2 3 
CULCT 1 1 1 0 0 1 
HCT 1 1 1 0 0 1 
SENS 1 1 1 0 0 1 
CSF 4 4 1 0 0 4 
DIFF 1 1 1 0 0 1 
LDH 2 5 1 1 3 5 
HERP 1 1 1 0 0 1 
CULUR 1 1 1 0 0 1 
TBCUL 1 1 1 0 0 1 
TBA 1 4 1 0 0 4 
FBC 24 34 1 3 3-4 34 
CULPU 1 1 1 0 0 1 
CULBC 1 1 1 0 0 1 
TOXO 1 1 1 0 0 1 
CMV 1 1 1 0 0 1 
HB 1 1 1 0 0 1 
TOTAL  163  20  163 
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CHAPTER 5 
DISCUSSION 
 
5.1 INTRODUCTION 
 
This was the first study in District Hospital in the Northern Cape and it was undertaken 
against the backdrop of a rise in the laboratory expenditure in the Province and the 
austerity measures currently undertaken by the Department.  
 
Data of a total of 52 mothers and 30 neonates who had been admitted in the Maternity 
unit of the Hospital during a period of one month was reviewed. The aim was to 
describe laboratory tests undertaken in the Maternity unit of Gordonia Hospital during 
the study period and also to document their costs and recording of results in patient 
files. 
 
5.2 LABORATORY TESTS PERFORMED AND THE CLINICAL PROFILE OF 
PATIENTS IN THE MATERNITY UNIT 
 
A total number of 183 patients were admitted during the study period. Fifty two 
patients (28.4 %) had laboratory tests. Eighty two mothers (44%) were not tested 
because the prescribed test were already done at primary health care level and was 
recorded as such. A total of 27% of patient files recorded in the maternity register 
could not be found at the facility. Laboratory tests were also done for 30 babies (16%) 
out of 183 born at the facility during the study period. Test for these babies were 
necessary as a result of their medical condition at birth. Sixty four percent (153) babies 
did not need to be tested.  
 
5.2.1.       NUMBER OF TESTS DONE         
 
5.2.1.1    MOTHERS 
 
There were a total of 524 tests done for mothers within 24 categories. The most 
common tests done during the period were Uric Acid, Urea creatinine & Electrolytes, 
and Platelets, Aspartate transaminase, Lactate dehydrogenase, Haemoglobin and 
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Alanine transaminase.   Most of the patients tested, presented with hypertensive 
disorders of pregnancies and more specifically pre-eclampsia.   The Guidelines for 
Maternity Care in South Africa (2007:26)  states that women admitted with pre-
eclampsia needs full blood count including platelet count; serum urea and creatinine; 
serum uric acid; aspartate transaminase  and urine dipstick test for protein. These 
tests need to be repeated weekly depending on the grade of pre-eclampsia.  
 
5.2.1.2.    NEONATES 
 
There were a total of 163 tests done within 21 categories of tests.  The common tests 
done during the period was Full Blood Count, Paediatric Bilirubin, and C - reactive 
protein. The highest number of tests done was Paediatric Bilirubin (PBIL), followed by 
Full Blood Count and C-reactive protein (CRP). Full blood count was done as a 
baseline, routine tests for infants and the bilirubin and C - reactive protein were done 
for babies with neonatal jaundice. Although doctors at the hospital indicated that the 
hospital’s protocol states that bilirubin test have to be taken every second day, the 
research shows that in some cases the tests were requested on a daily basis. .  
 
5.2.2.      PROFILE OF PATIENTS 
  
5.2.2.1.   AGE 
 
The mean age (average age) for the participants is 26.4 years and the standard 
deviation (average deviation from the mean age) is 6.1 year. Patients tested within the 
age ranges 26-35 years and 19-25 years were 46, 2% and 38.5% respectively. These 
ages are also the reproductive years of women. . Only 9, 6 % and 5.7% were within 
the age ranges of 13-18 (teenage) and ≥35 years respectively.  
 
5.2.2.2.    GRAVIDITY  
 
In twenty eight percent or 15 of women tested it were the 1st pregnancy, 40.4 % or 21 
had a gravidity status of 2-3 pregnancies; whiles 16 or 30.8% of patients were in the 
gravidity range of ≥4. According to the Guidelines for Maternity Care in South Africa of 
2007, pregnant women most susceptible for pre-eclampsia are women with 1st 
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pregnancies in the teenage and elderly ranges, women with multiple pregnancies with 
new partners, and women of age ≥35 years.  
 
5.2.2.3.    PARITY  
 
Forty percent of women tested were in the parity range of 1-3 children, whiles 30.8% 
and 28.8% of women were in the parity ranges of ≥4 and 0 children respectively.  
 
5.3 COST OF LABORATORY TESTS AND HEALTH EXPENDITURE 
 
5.3.1         COSTS OF LABORATORY TESTS 
 
5.3.1.1      MOTHERS 
 
The expenditure for tests done for mothers was 62.1% of the total laboratory costs for 
the maternity unit. The most expensive tests were Liver Function Tests (LFT) at 
R256.56/test, followed by histology at R187.17/tests, urine protein (UPROT) at 
R140.58/test and UEAC at R96.28/test. Other expensive tests were sensitivity at 
R57.88/test, full blood count (FBC) at R48.30/test and culture urine (CULUR) at 
R45.63/test. The rest of the test ranged from R37.84 till R15.03. 
 
The highest proportion spend for mothers per category of tests were those of UECA 
with 23.3%, followed by 9.7 % for LFT, 8.5% for urine protein, 8.2% for AST, ALT and 
LDH. Those were the common tests requested.  
 
The amount for the total repeat tests for mothers was R1985.12, 15% of the total 
expenditure for laboratory tests for mothers and a 46% of total repeat tests. 
 
5.3.1.2      NOENATES 
 
The expenditure for tests done for neonates was 33.8% of the total laboratory costs for 
the maternity unit. The most expensive tests for neonates were Cystic Fibrosis (CSF) 
at R106.19/test, followed by UEAC at R96.28/tests, TB Culture at R72.98/test, C-
reactive protein(CRP)  at R60.77/test,  Full blood Count (FBC) at R48.30/test and 
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Paediatric Bilirubin at R51.76. Other expensive tests were, culture urine (CULUR) at 
R45.63/test and LDH at R37.84/test. The rest of the test ranged from R36.73 till 
R15.03. 
 
The highest proportion spend  on tests were those of paediatric bilirubin  with 26.9%, 
followed by 24.5 % for CRP, 22.8% for full blood count (FBC) and 6.6 % for UECA. 
Those were the most common tests done. 
 
The cost for the total repeat tests for neonates was R2364.09 which is 32.8% of the 
total laboratory expenditure for neonates. 
 
5.3.2.        HEALTH EXPENDITURE 
 
The total expenditure for Gordonia Hospital during the study period was 
R27 719 475.84. The total expenditure for laboratory services for at the Hospital 
during the study period was R423 470.17. The total laboratory costs for the maternity 
unit during the study period was R21 280.The expenditure for laboratory tests at the 
maternity unit as a proportion of total laboratory expenditure of the hospital is 5% and 
as a proportion of the total hospital expenditure is 0.08%. 
 
The proportion spends on mothers was 62.1% of the total maternity unit expenditure, 
whiles the proportion for neonates was 33.8%. A 4.1% was spending on administrative 
costs. 
 
A total amount of R4 349.21 was spending on repeat tests, 20.4% of the total 
laboratory expenditure for the maternity unit. Repeat tests were done on both mothers 
and babies.  
 
 All tests were recorded in the patient files which indicated no unnecessary laboratory 
costs.    
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5.4 THE RECORDING OF TEST RESULTS BY DOCTORS IN PATIENT 
FILES AND TURN-AROUND TIME OF TEST 
 
5.4.1.        MOTHERS 
 
83.4% of tests results were back within a day which is within the norm. A total of 
16.6% of test results were returned within 2days. The categories where results were 
returned within 2days were Rhesus factor (RH), Genital swap (CULGE), uric acid (UA) 
and urine culture. 
 
Repeat tests were done for 41.6 % of the total categories of tests. The most tests that 
were repeated were within a range of 1-3. Repeat tests were done for uric acid, 
UECA, PLT, and for AST and HB. This relates to the fact that most mothers tested 
were diagnosed with pre-eclampsia and it was therefore necessary to repeat the 
specific test. All tests were recorded by the doctors in the patient files. 
 
5.4.2         NEONATES 
 
All test results were received and recorded the same day. Repeat tests were done for 
19 % of the total categories of tests. The most tests that were repeated were within a 
range of 1-3. The high number of repeat tests happened for paediatric bilirubin, full 
blood count and CRP. These were also the test that was repeated according to the 
internal guideline of the hospital. Although the guideline stated for bilirubin every two 
days, the research shows in some cases tests were repeated daily. All tests were 
recorded by the doctors in the patient files. 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
6.1 CONCLUSIONS RELATED TO THE OBJECTIVES OF THE STUDY 
 
6.1.1 LABORARORY TESTS PERFORMED AND PROFILES OF PATIENTS IN 
THE MATERNITY UNIT  
 
Gordonia Hospital on an average admits 180 patients per month per year in the 
maternity unit. The study showed that for around 28% of the in - patients, laboratory 
tests are requested. Tests were requested mainly for patients with hypertensive 
disorders of pregnancy and more specific pre-eclampsia.  46.6 % of patients are in the 
reproductive ranges of age (22 -29).  Most patients tested were in the gravidity range 
of 2-3 pregnancies, whiles parity was in the range of 1-3 children.    
 
6.1.2 THE COSTS OF LABORATORY TESTS UNDERTAKEN IN THE 
MATERNITY UNIT  
 
It can be concluded that laboratory expenditure from the maternity unit was 5% of the 
total laboratory expenditure of the hospital for September 2009. The costs of 
laboratory tests for mothers are twice more than those for neonates. The repeated 
tests calculated to 20.4 % of the total laboratory expenditure of the maternity unit and 
are therefore  an area of concern.  There is a concern around the repeat tests for the 
babies around the number and the frequency of repeats.  
 
6.1.3 THE RECORDING OF TEST RESULTS BY DOCTORS IN PATIENT FILES 
AND TURN-AROUND TIME OF TEST 
 
Test turnaround times were mostly within 1day except for a few that returned within 
two days. Almost all tests were recorded in the patient files for the study period which 
showed no wastage. 
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6.2 LIMITATIONS OF THE STUDY 
 
Incomplete patient records and missing files were a limitation to the study.  
 
6.3 RECOMMENDATIONS 
 
6.3.1 USE OF FINDINGS OF THE STUDY  
 
The results of this study will be presented to the District and Provincial Health 
Departments with the view of presenting a model that can be used in other hospitals 
with similar challenges. It can also be used to improve maternal health care because 
it has showed that most tests were linked to hypertensive disorders of pregnancies. 
Emphasis therefore will be on the antenatal services within primary health care. The 
study outcomes also showed the gaps in the record system to be improved on and 
outlined areas of saving on laboratory costs.  It further shows the good practises in 
the hospital.  
 
6.3.2 FUTURE RESEARCH  
 
Future research needs to look at repeated tests as well as the use of tests for 
improvement of the clinical conditions of patients. Another area for future research is 
the reason why patient files were lost.  
 
6.4 SUMMARY AND CONCLUSIONS 
 
The study showed that laboratory tests from the maternity unit of the hospital are 
mostly requested for mothers who presents with hypertensive disorders of 
pregnancies, especially pre-eclampsia, and for babies with neonatal jaundice. 
Laboratory costs for the unit are around 5% of the total hospital laboratory costs and 
test turn-around times as well as recording of test results in patient files are of a good 
standard.   
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